Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01209234 · ClinicalTrials.gov registry record · NA
Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 2,140
- Enrollment target
NCT01209234: Completed NA study, sponsored by University of California, Irvine.
NCT01209234 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 2,140 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01209234, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,140 participants
- Enrollment target
Study Summary
This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA-positive patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.
Primary Outcome
Time in days to MRSA inpatient or outpatient infection (analyzed with the use of unadjusted Cox proportional-hazard models to identify time to infection; the results we are reporting are number of participants who had an infection event at one year post discharge)
Interventions
- BEHAVIORAL Standard-of-Care Education
- DRUG MRSA Decolonization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,140 participants |
| Start Date | 2011-01 |
| Est. Completion | 2019-01 |
| Phase | NA |
What the finished NCT01209234 record still lists
NCT01209234 is an interventional study that assigns participants to a tested intervention. Its 2,140 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% higher).
The record links to 0 conditions, and to 2 interventions - of which Standard-of-Care Education is the first listed.
NCT01209234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01209234 about?
NCT01209234 is a clinical study titled "Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance". This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventi...
What is the current status of trial NCT01209234?
This trial is currently completed. It is a NA study. The enrollment target is 2,140 participants. The study started on 2011-01. Estimated completion is 2019-01.
What interventions are being tested in trial NCT01209234?
The interventions under investigation include: Standard-of-Care Education (BEHAVIORAL), MRSA Decolonization (DRUG).
Who is sponsoring clinical trial NCT01209234?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01209234's enrollment target sits among peer trials
2,140 49th of 2000 higher than 1,952 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03488693 · 2,140 participants · Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
- NCT06598475 · 2,142 participants · NA
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
- NCT05650658 · 2,136 participants · NA
Left vs Left Randomized Clinical Trial
- NCT05805709 · 2,145 participants · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia